quinoline has been researched along with Glioma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, TC; Cho, HY; Golden, EB; Hofman, FM; Louie, SG; Schönthal, AH | 1 |
| Chang, JG; Chang, YS; Chen, JC; Chen, YF; Chen, YL; Hsiao, PC; Lee, CC; Liao, HF; Tseng, CH; Tzeng, CC | 1 |
| Anzini, M; Bruni, G; Cappelli, A; De Benedetti, PG; Doucet, E; Hamon, M; Langer, T; Makovec, F; Mennuni, L; Menziani, MC; Romeo, MR; Vomero, S | 1 |
3 other study(ies) available for quinoline and Glioma
| Article | Year |
|---|---|
Quinoline-based antimalarial drugs: a novel class of autophagy inhibitors.
Topics: Animals; Antimalarials; Antineoplastic Agents; Apoptosis; Autophagy; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Endoplasmic Reticulum Stress; Gene Expression Regulation, Neoplastic; Glioma; Humans; Mice, Nude; Poly(ADP-ribose) Polymerases; Quinolines; Xenograft Model Antitumor Assays | 2015 |
TCH1036, a indeno[1,2-c]quinoline derivative, potentially inhibited the growth of human brain malignant glioma (GBM) 8401 cells via suppression of the expression of Suv39h1 and PARP.
Topics: Brain Neoplasms; Catalytic Domain; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Glioma; Humans; Methyltransferases; Molecular Docking Simulation; Oximes; Poly (ADP-Ribose) Polymerase-1; Quinolines; Repressor Proteins; RNA, Messenger | 2016 |
Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 1. Mapping the central 5-HT3 receptor binding site by arylpiperazine derivatives.
Topics: Animals; Benzene; Binding Sites; Glioma; Guanidine; Mice; Models, Molecular; Molecular Structure; Neuroblastoma; Phenanthridines; Piperazines; Quinolines; Quipazine; Rats; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Serotonin Receptor Agonists; Structure-Activity Relationship; Tumor Cells, Cultured | 1998 |